Background: A previous study bas suggested that BWdobacterium animalis DN-173 010 shortens the colonic transit time in women. Aim: To confirm this efIect and to determine whether modifications of the faecal bacterial mass and/or faecal secondary bile salts may be the explanation. Methods: A double-blind. cross-over study was performed. Thirty-six healthy women were studied in four consecutive 10-day periods. During periods 2 and 4. they ingested three 125 g ClipS per clay of a fermented milk which was either a product containing B. animalisDN-173 010 or a control without bifidobacteria.
INTRODUCTION
There is a growing interest in functional food which can 'beneficially affect one or more target functions in the body in a way that is relevant either to promoting the state of well-being and health and/or reducing the risk of disease'. Probiotics belong to these functional foods and have been defined as 'microbial cell preparations or components of microbial relis that have a beneikial effect on the health and well~being of the hosf.1.2 Bifidobacteria represent about 20% of the cultivable faecal bacteria in adults and up to 80% ininfants. Saille strains which are used in fermented milks have a high survival capacity in the gastrointestinal tract and exhibit probiotic properties in the colon.3-9 Colonic transit disturbances (constipation and irritable bowel syndrome) are frequent and represent an important target for functional food. including probiotics.l Probiotics are believed to influence intestinal transit; however. the evidence is poor as randomized controlled studies are lacking. 2 An open study has suggested that the ingestion of propionibacteria may slow clown the P. MARTEAU et al. 588 similar colour, taste, texture and lactose content. The Bifidus product (Bifidus) was the commercial product 'BIO', i.e. a semi-skimmed milk fermented by yoghurt cultures and B. animalis strain DN-173 010. The contrai product was the same fermented milk without bifidobacteria (i.e. fermented only with yoghurt cultures). The contrai and Bifidus products contained at least 108 colony-forming units/g (CFU/g) of yoghurt cultures on the first day of each ingestion period. The Bifidus product contained additionally between 5 x 107 and 108 CFU/g of B. animalis strain DN-173 010.
Experimental design
The study comprised four consecutive periods, i.e. a ID-clay run-in period and two ID-clay ingestion periods with an interval of 10 days between them. Subjects were asked to retain their normal stable diet, except that milk, sauces and fermented dairy products, including yoghurt and soft cheeses, were excluded throughout the study. During the ingestion periods, the subjects were given, in a randomized, double-blind, cross-over fashion, three 125 g ClipS per clay of either contrai or Bifidus. Half of the subjects received the contrai before Bifidus (and were referred to as group A), and half received the Bifidus before the contrai (group B). The subjects recorded the number of bowel movements in the last week of each period. ln the last 3 days of the run-inand each test period, the subjects ingested every clay 20 identical radio-opaque pellets at 09.00 h, and an abdominal X-ray was taken on the last day. Total and segmentaI colonic transit times were calculated according to the distribution of the markers in the different segments of the bowel, using the formula: transit time in the left colon in healthy men. ID We observed. in a previous study, that a milk fermented by Bifidobacterium animalis strain DN-173 010 shortened th~ colonic transit time fi women, particularly those with a long transit time.ll The effect on faecal weight and stool frequency was not assessed and the mechanism is unknown. We hypothesized that an increase in the faecal bacterial mass and/or in the secondary bile salts in the colon may be responsible for this effect. We speculated tnat the probiotic bifidobacteria which survive to the faecal stage may significantly increase the faecal bacterial mass and/or stimulate colonic motility by enhancing colonic concentrations of seconclary bile salts. Indeed, some bifidobacteria may directly metabolize bile acids12. 13 and some probiotics influence bile salt metabolism by endogenous flora.14 This study aimed to confirm, in a double-blind, randomized, controlled trial, that B. animalis strain DN-173 010 shortens the colonic transit time in women, aQd to establish whether this effect is due to an incr~ased faecal bacterial mass or an increase in secondary faecal bile acids.
SUBJECTS AND METHODS

Subjects
This randomized, double-blind. cross-over study was conducted in three centres in France (Clermont-Ferrand, Marseille, Paris). Inclusion criteria were: healthy female volunteers. aged 18-45 years; absence of pregnancy; body mass index < 25; absence of a past history of digestive disease; absence of constipation; and absence of symptoms of irritable bowel syndrome. Each volunteer provided written consent to the protocol which had been approved by the Ethics Committee of the Factulté de Médecine. Université Marseille Il. Thirtysix womenwere included (12 in each centre). Four were excluded because the study endpoint could not be assessed (errors in the timing of pellet ingestion). The 32 volunteers in whom the study endpoints were measured had a mean age of 27 ::!: 7 years, a body weight of 55 ::!: 5 kg and a height of 164 ::!: 6 cm. A staal analysis was performed in the 12 volunteers followed in Paris. AlI stools in the last 3 days of each study period were collected, and brought to the metabolic ward within 12 h in closed boxes carried in a larger box which was filled with ice. Faecal pH was measured using a pH-meter (Radiometer, Copenhagen. Denmark). Samples were then frozen and kept at RESULTS Groups A and B did not differ significantly at the end of the run-in period for any transit time or faecal parameter, except for pH (Table 1) .
Colonic transit time and number of bowel movements
The total colonic transit time and the sigmoid transit time were significantly shorter after Bifidus than after contrai consumption ( Table 2 ). They did not differ significantly from those measured at the end of the run-in period with any of the treatments (Table 2) . Individual results are shawn in Figures 1 and 2 . ln the sub-group of subjects with an initial transit time above 40 h (n = 21), a significant decrease in the total colonic transit time was observed during the Bifidus consumption period in comparison with the run-in period and the "control period (Table 2) . ln this sub-group, a significant decrease in the sigmoid transit time was also observed during the Bifidus consumption period in comparison with the runin period and the contrai period ( Table 2 ). The number of stools per week did not significantly differ between theBifidus,contr 2.7,7.6:t 2.8 and 7.0 :t 1.6 stools/week, respectively).
Statistical analysis
Study end points. The major endpoint was the comparison of the total colonic transit time after consumption of Bifidus vs. contrai. Secondary endpoints were the segmentaI colonic transit times (the right. left and sigmoid colon). staal frequency. faecal weight. faecal bacterial mass. faecal pH and faecal bile salts (individual bile salts. pooled primary and pooled secondary bile salts). Comparisons between each product period and run-in period were also performed. ln our previous study using the saille method. the mean total colonic transit time in healthy volunteers was 36:t 16 h (mean :t s.d.). To test the hypothesis of a difference of 12 h with an IX value of 0.05 and a f3 value of 0.15. we calculated that 32 subjects were needed. and decided to products had no significant effect on the faecal bacterial mass (treatment effect: P = 0.938), but a significant increase in the faecal bacterial mass was observed during the second consumption period in bath groups A and B (period effect: P = 0.042) ( The faecal concentrations of total secondary bile acids, deoxycholic acid and lithocholic acid were not significantly affected during any period (Table 4) . There was an increase in stool concentration of primary bile acids during the Bifidus period in comparison with the control period which approached but did not achieve statistical significance (Table 4 ; P = 0.079).
efIect of probiotics on intestinal transit. bas been poorly studied. Bouglé et al. reported that the administration of propionibacteria may slow clown tra~sit in the left colon in healthy men; however, their study was open and did not use a contrai group.10 The present study demonstrates, for the first time, that a probiotic strain may significantly shorten the colonic transit time. It is in accordance with our previous trial, which suggested that B. animalis DN-173 010 shortened the sigmoid transit time in women.11 This strain bas a high survival in the small and large intestine when it is ingested in a fermented dairy product.6. 7. 9 Although the clinical relevance of our results is open to discussion, it bas been shawn that modulation of the intestinal motility can be obtained with probiotics, and a rational mechanism for Saille of their efIects bas been provided. None of the mechanisms evaluated in the present study (increase in faecal weight, especially in faecal bacterial mass, and modifications in secondary bile salt excretion) can explain the efIect of the probiotic on the colonic transit time. It is possible that saille efIects of probiotics on colonic bacteria may occur slowly and may remain for more than 10 days, and this may be a limitation of our cross-over study design. Other studies have shawn that modifications of faecal enzymes induced by probiotic ingestion may indeed last for up to 3 weeks after cessation of ingestion. 9. 21 Future crossover studies aimed at assessing the efIects of prObiotics on the colon ecosystem should include longer washout periods. ln the present study, an efIect of the strain on the colonic transit time was observed, while the faecal bacterial mass and bile acids were not significantly influenced.
DISCUSSION
This double-blind. randomized. controlled study demonstrates that healthy women have shorter total colonic and sigmoid transit times when they ingest 3 clips/clay of a fermented milk containing yoghurt cultures plus B. animalis DN-173 010 vs. the saille product without the latter strain. The faecal weight. bacterial mass and faecal excretion of secondary bile salts are not significantly influenced.
Several studies have shawn that probiotics may influence intestinal disturbances and. in particular. may prevent or shorten the duration of diarrhoea in infants or adults with acute gastroenteritis.2. 18-21 The Saille bifidobacteria can deconjugate and dehydroxylate bile salts. i.e. con vert conjugated primary bile salts into free secondary bile salts which can stimulate colonic motility and secretion.12. 13 ln the present study, B. anirnalis DN-173 010 ingestion did not influence the faecal excretion of secondary bile salts. We believe that this is a good thing, as secondary bile salts may increase the risk of colon cancer.22-24 The shortening of the colonic transit time was therefore not due to significant bile salt modifications. The concentrations of primary bile acid tended to increase after consumption of the Bifidus product and this could be due to shortening of the colonic transit time. 25 The mechanism of the efIect of the tested strain on the colon motility remains unknown. One may hypothesize that a product of bacterial origin may decrease the sigmoid tonus and or stimulate the colonic motility. One of these products might be phloroglucinol which can be produced by Saille colonic bacteria and has strong efIects on colonic motility.26. 27 Further studies should be performed to evaluate this hypothesis. We conclude that the regular consumption of a Bifidus fermented milk (BIO. Danone) influenced the colonic motor function. This efIect is specific to the probiotic strain as it was not observed with a contrai fermented milk. Further studies are needed to determine the mechanism. and also to assess the clinical efficacy of the BIO product in constipated patients.
